bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression

International Journal of Cancer

Volumn 69, Issue 2, 1996, Pages 114-119

  Aguilar Santelises, Miguel ^a,b   Rottenberg, Martín E ^a   Lewin, Nongnit ^c   Mellstedt, Håkan ^c   Jondal, Mikael ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; DEXAMETHASONE; GLUCOCORTICOID; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; ONCOGENE; PRIORITY JOURNAL; TUMOR GROWTH;

AGED; BASE SEQUENCE; BCL-2-ASSOCIATED X PROTEIN; CELL DIVISION; CELL SURVIVAL; DEXAMETHASONE; DNA DAMAGE; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; LEUKEMIA, B-CELL; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029970093     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960422)69:2<114::AID-IJC8>3.0.CO;2-3     Document Type: Article

References (40)

1. AGUILAR-SANTELISES, M., MAGNUSSON, K.P., WIMAN, K.G., MELLSTEDT, H. and JONDAL, M., Progressive B-cell chronic lymphocytic leukemia frequently exhibits aberrant p53 expression. Int. J. Cancer, 58, 474-479 (1994a).
2. AGUILAR-SANTELISES, M., MELLSTEDT, H. and JONDAL, M., Leukemic cells from progressive B-CLL respond strongly to growth stimulation in vitro. Leukemia. 8, 1146-1152 (1994b).
3. BARINAGA, M., Cell suicide: by ICE, not fire. Science, 263, 754-756 (1994).
4. BOISE, L.H., GONZALEZ-GARCIA, M., POSTEMA, C.E., DING, L., LINDSTEN, T., TURKA, L.A., MAO, X., NUNEZ, G. and THOMPSON, C.B., Bcl-X, a Bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74, 597-608 (1993)
5. BURTON, K., A study of the conditions and mechanisms of the dyphenilamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem. J., 62, 315-323 (1956).
6. CAELLES, C., HELMBERG, A. and KARIN, M., p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature. 370, 220-223 (1994).
7. CAMPANA, D., COUSTAN-SMITH, E., MANABE, A., BUSCHLE, M., RAIMONDI, S.C., BEHM, F.G., ASHMUN, R., ARICO, M., BIONDI, A. and PUI, C.H., Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by over-expression of Bcl-2 protein. Blood, 81, 1025-1031 (1993).
8. COMPOS, L., ROUALLT, J.P., SABIDO, O., ORIOL, P., ROUBI, N., VASSLLON, C., ARCHIMBAUD, E., MAGAUD, J.P. and GUYOTAT, D., High expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood. 81, 3091-3096 (1993).
9. DE FRANCO, A.L., Bcl-2 to the rescue. Curr. Biol. 2, 95-97 (1992).
10. DLMONT, I.E., JAUNIAUX, J.C. and ROGER, P.P., The cyclic AMP-mediated stimulation of cell proliferation TIBS, 14, 67-71 (1989).
11. HANADA, M., DELIA, D., AIELLO, A., STADMAUER, E. and REED, J.C., Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood, 82, 1820-1828 (1993).
12. HOCKENBERY, D., NUÑEZ, G., MILLIMAN, C., SCHREIBER, R.D. and KORSMEYER, S.J., Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348, 334-336 (1990).
13. HOCKENBERY, D.M., OLTVAI, Z.N., YIN, X.M., MILLIMAN, C.L. and KORSVIEYER, S.J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75, 241-251 (1993).
14. KORSMEYER, S.J., Bcl-2: a represser of lymphocyte death. Immunol Today, 13, 285-288 (1992a).
15. KORSMEYER, S.J., Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood, 80, 879-886 (1992b).
16. KORSMEYER, S.J., SHUTTER, J.R., VEIS, D.J., MERRY, D.E. and OLTVAI, Z.N., Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol., 4, 327-332 (1993).
17. LOWE, S.W., SCHMITT, E.M., SMITH, S.W., OSBORNE, B.A. and JACKS, T., p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362, 847-849 (1993).
18. MCCONKEY, D.J., AGUII-AR-SANTELISES, M., HARTZELL, P., ERIKSSON, I., MELLSTEDT, H., ORRENIUS, S. and JONDAL, M., Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. J. Immunol., 146, 1072-1076 (1991).
19. MCCONCKEY, D.J., ORRENIUS, S. and JONDAL, M., Cellular signalling in programmed cell death (apoptosis). Immunol. Today, 11, 120-121 (1990).
20. MCCONKEY, D.J., ORRENIUS, S., OKRET, S. and JONDAL, M., Cyclic AMP potentiates glucocorticoid-induced endogenous endonuclease activation in thymocytes. FASEB J., 7, 580-585 (1993).
21. MIYASHITA, T., KRAJEWSKI, S., KRAJEWSKA, M., WANG, H.G., LIN. H K., LIEBERMANN, D.A., HOFFMAN, B. and REED, J.C., Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9, 1799-1805 (1994).
22. NUÑEZ, G., LONDON, L., HOCKENBERY, D., ALEXANDER, M., MCKEARN, J.P. and KORSMEYER, S.J., Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor deprived hematopoietic cell lines. J. Immunol., 144, 3602-3610 (1990).
23. NUÑEZ, G., MERINO, R., GRILLOT, D. and GONZALEZ-GARCIA, M., Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival. Immunol. Today, 15, 582-588 (1994).
24. OLTVAI, Z.N., MILLIMAN, C.L. and KORSMEYER, S.J., Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax. that accelerates programmed cell death. Cell, 74, 609-619 (1993).
25. PEZZELLA, F., TSE, A.G.D., CORDELL, J.L., PULFORD, K.A.F., GATTER, K.C. and MASON, D.Y., Expression of the Bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am. J. Pathol, 137, 225-232 (1990).
26. RAI, K.R., SAWITSKY, A., CRONKITE, E.P., CHANANA, A.D., LEVY, R.N. and PASTERNACK, B.S., Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219-234 (1975).
27. SCHENA, M., LARSSON, L.G., GOTTARDI, D., GAIDANO, G., CARLSSON, M., NILSSON, K. and CALIGARIS-CAPPIO, F., Growth- and differentiation-associated expression of Bcl-2 in B-chronic lymphocytic leukemia cells. Blood, 79, 2981-2989 (1992).
28. SELVAKUMARAN, M., LIN, H.K., MIYASHITA, T., WANG, H.G., KRAJEWSKI, S., REED, J.C., HOFFMAN, B. and LIEBERMANN, D., Immediate early up-regulation of bax expression by p53 but not TGFβ1: a paradigm for distinct apoptotic pathways. Oncogene, 9, 1791-1798 (1994).
29. SENTMAN, C.L., SHUTTER, J.R., HOCKENBERY, D., KANAGAWA, O. and KORSMEYER, S.J., Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67, 879-888 (1991).
30. SIEBERT, P.D. and LARRICK, J.W., Competitive PCR. Nature (Lond.). 359, 557-558 (1992).
31. SILVER, R.T., SAWITSKY A., RAI, K., HOLLAND, J.F. and GLIDEWELL, O., Guidelines for protocol studies in chronic lymphocytic leukemia. Am. J. Hematol. 4, 343-358 (1978).
32. STRASSER, A., HARRIS, A.W., JACKS, T. and CORY, S., DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell, 79, 329-339 (1994).
33. TANAYAMA, S., SATO, T., KRAJEWSKI, S., KOCHEL, K., IRIE, S., MILLAN, J.A. and REED, J C., Cloning and functional analysis of BAG-1: a novel Bcl-2 binding protein with anti-cell death activity. Cell. 80, 279-284 (1995).
34. α protein in human B lymphoblastoid cell. Oncogene, 4, 1331-1336 (1989).
35. TSUJIMOTO, Y., COSSMAN, J., JAFFE, E. and CROCEM C.M., Involvement of the Bcl-2 gene in human follicular lymphoma. Science, 228, 1440-1443 (1985).
36. WILKINSON, M., RNA isolation, a mini-prep method. Nucleic Acids Res., 16, 10933 (1988).
37. WYLLIE, A.H., Death gets a brake. Nature (Lond.), 369, 272-273 (1994).
38. L and Bcl-2, displaces Bax and promotes cell death. Cell, 80, 285-291 (1995).
39. YIN, X.M., OLTVAI, Z.N. and KORSMEYER, S.J., BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerisation with Bax. Nature (Lond.), 369, 321-323 (1994).
40. ZHAN, Q., FAN, S., BAE, I., GUILLOUF, C., LIEBERMANN, D.A., O'CONNOR, P.M. and FORNACE, A.J., Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene, 9, 3743-3751 (1994).